Inventor

Carol Bachand

Inventor
Candiac, CA

Overview

31→
Patents
1977–2017
Patent span
Human necessities
Primary field (CPC A)

Patents· 31 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07HSugars5%
PatentTitleYear
9,758,487'Hepatitis C virus inhibitors'20179,227,961'Hepatitis C virus inhibitors'20169,018,390'Hepatitis C virus inhibitors'20158,846,023'Hepatitis C virus inhibitors'20148,642,025'Hepatitis C virus inhibitors'20148,574,563'Hepatitis C virus inhibitors'20138,492,553'Hepatitis C virus inhibitors'20138,303,944'Hepatitis C virus inhibitors'20128,288,562'Hepatitis C virus inhibitors'20128,147,818'Hepatitis C virus inhibitors'20128,143,414'Hepatitis C virus inhibitors'20128,093,243'Hepatitis C virus inhibitors'20127,915,283'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20117,759,495'Hepatitis C virus inhibitors'20107,745,636'Hepatitis C virus inhibitors'20107,741,347'Hepatitis C virus inhibitors'20107,704,992'Hepatitis C virus inhibitors'20107,659,270'Hepatitis C virus inhibitors'20107,501,419'4-Squarylpiperazine derivatives as antiviral agents'20097,348,337'Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides'20087,138,377'Topoisomerase inhibitors'20066,855,698'Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles'20056,677,450'Topoisomerase inhibitors'20046,653,290'Tumor proliferation inhibitors'20035,672,701'4-substituted alkyl carbapenem antibiotics'19975,116,833'Antibiotic C-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof'19924,665,169'Carbapenem antibiotics'19874,202,982'Process for the preparation of 14-hydroxymorphinan derivatives'19804,153,603'(.+-.)-2-Cyclobutylmethyl-9.alpha.,10.beta.-dihydroxy-1.beta.-(p-alkox y-benzyl)perhydroisoquinoline'19794,058,531'Process for the preparation of 14-hydroxymorphinan derivatives'19774,052,389'Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one'1977

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1977–1980Based in Cote Ste-Catherine, CA· patent location history
1987–2017Based in Candiac, CA· patent location history
1992–2017Patents assigned to BRISTOL MYERS SQUIBB CO (26)· patent assignee history
2012–2013Patents assigned to BACHAND CAROL (7)· patent assignee history
2012–2013Patents assigned to LAVOIE RICO (7)· patent assignee history
2012–2013Patents assigned to RUEDIGER EDWARD H (7)· patent assignee history
2012–2013Patents assigned to BELEMA MAKONEN (6)· patent assignee history
2016Based in Quebec, CA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO261992–2017
BACHAND CAROLself72012–2013
LAVOIE RICO72012–2013
RUEDIGER EDWARD H72012–2013
BELEMA MAKONEN62012–2013
Locations
LocationPatentsSpan
Candiac, CA261987–2017
Cote Ste-Catherine, CA41977–1980
Quebec, CA12016